Extrusion tooling
Search documents
Exco Technologies Limited Announces Results for Fourth Quarter and Year Ended September 30, 2025
Globenewswireยท 2025-11-26 22:01
Core Viewpoint - Exco Technologies Limited reported its financial results for the fourth quarter and fiscal year ended September 30, 2025, highlighting resilience amid industry challenges and a focus on future growth opportunities [3][15]. Financial Performance - Consolidated sales for Q4 2025 were $150.7 million, a decrease of 3% from $155.4 million in Q4 2024 [4]. - Net income for Q4 was $8.2 million ($0.22 per share), compared to $7.7 million ($0.20 per share) in the previous year [10]. - EBITDA for Q4 was $18.0 million, representing 12% of sales, down from $20.6 million (13%) in Q4 2024 [13]. - Annual sales totaled $615.3 million, down from $637.8 million in the previous year [8]. Segment Performance - The Automotive Solutions segment reported Q4 sales of $77.9 million, a 2% decline due to program-launch delays and an unfavorable vehicle mix [5]. - The Casting and Extrusion segment had Q4 sales of $72.7 million, a decrease of 5%, although extrusion tooling sales increased due to diverse end markets [7]. - Pretax profit in the Automotive Solutions segment fell by 35% to $5.1 million, while the Casting and Extrusion segment's pretax profit decreased by 29% to $4.5 million [11][12]. Cash Flow and Dividends - Free cash flow for Q4 was $13.8 million, with annual free cash flow amounting to $40.7 million [8]. - The company declared a quarterly dividend of $0.105 per common share, payable on December 31, 2025 [1]. Strategic Outlook - The company anticipates benefiting from new program launches and reshoring trends, which are expected to support sales and margin recovery [6][17]. - Exco is well-positioned to navigate ongoing trade policy developments, particularly with products compliant with USMCA rules [16]. - Management remains optimistic about long-term growth despite near-term headwinds, focusing on operational efficiency and market share gains [15][17].